About PerSimiO
PerSimiO is a Healthcare company founded in 2015 by Eitan Segall. It develops AI-based simulations for predicting bone fracture risks accurately. It operates on a B2B model. Its chief executive is Eitan Segall. PerSimiO offers products and services including Simfini, Simfini-SENIOR, and Simfini-TUMOR. Its focus areas include Medical Technology, Diagnostic Tools, Bone Strength Analysis and AI and Biomechanics. Its competitors include Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
PerSimiO provides advanced fracture risk assessment through machine learning and finite element analysis based on CT scans. The company offers Simfini, a validated system for evaluating bone strength in healthcare settings. Located in Beer-Sheva, Israel, it focuses on applications like hip fracture prediction and tumor risk analysis to aid clinical decisions and prevent unnecessary surgeries.
- Founders Eitan Segall
- SectorsHealthcare
- Email••••••••
- Website persimio.com
- Latest Funding Round$529K (USD), Grant
Oct 2015
- Investors
Products & Services of PerSimiO
PerSimiO offers a comprehensive portfolio of products and services, including Simfini, Simfini-SENIOR, and Simfini-TUMOR.
CT-based model for simulating bone responses to loads.
Tool to identify risks of subsequent hip fractures in patients.
System for assessing need for surgery in bone tumors.
Funding Insights of PerSimiO
- Total Rounds 1
- Last Round Grant — $529,000
- First Round $529,000
(Oct 2015)
- Investors Count 1
All 1 funding rounds of PerSimiO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $529,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in PerSimiO
PerSimiO has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ministry of Economy and industry.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | economy.gov.il | - |
Investor details for PerSimiO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PerSimiO
1 people are tracked at PerSimiO (1 in leadership).
| Name | Role | Group |
|---|---|---|
Eitan Segall | Co-Founder, CEO | Leadership |
Complete people profiles for PerSimiO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PerSimiO
2 dated milestones of PerSimiO, from founding to its latest funding, stage changes and deals.
- Founded PerSimiO is founded.
- Funding First funding round of $529K.
Competitors of PerSimiO
PerSimiO has 10 listed competitors in our database, 9 of them funded. They include Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tricemedical.com | 2012 | King Of Prussia, United States | $85.47M | 67 | Needle-based visualization devices for orthopedic diagnostics are developed. | |
| edgesurgical.com | 2015 | Chicago, United States | $16.99M | – | Digital depth gauges for orthopedic bone measurements are supplied. | |
| orthoscan.com | 2002 | Scottsdale, United States | $8.33M | 148 | Mini C-arms for orthopedic imaging are developed by OrthoScan. | |
| onicorp.com | 1997 | Boston, United States | $28M | – | MRI systems for extremity imaging are developed and marketed. | |
| bindex.fi | 2011 | Kuopio, Finland | – | – | Ultrasound-based POC device for osteoporosis screening is developed. | |
| focusmotion.io | 2012 | Los Angeles, United States | $250,000 | – | Provider of AI-based wearables and application for health, wellness and fitness | |
| rossumrobot.cn | 2017 | Haidian, China | $14.33M | – | Robotic surgical systems for orthopedic treatments are provided. | |
| mecuris.com | 2015 | Munich, Germany | $8.13M | 34 | Offers digital CAD/CAM solutions for designing orthopedic implants. | |
| voxelcare.com | 2009 | Elche, Spain | $5.5M | – | CAD/CAM systems for foot care and footwear are developed. | |
| echolightmedical.com | 2010 | Lecce, Italy | $4.4M | – | Radiation-free bone densitometers for osteoporosis assessment are developed. |
Detailed competitors of PerSimiO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Imaging Diagnostics
10 companies that operate in the same segment as PerSimiO (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | – | 91 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PerSimiO
PerSimiO was founded in 2015.
Eitan Segall is the current CEO of PerSimiO. They have also founded this company.
PerSimiO provides advanced fracture risk assessment through machine learning and finite element analysis based on CT scans. The company offers Simfini, a validated system for evaluating bone strength in healthcare settings. Located in Beer-Sheva, Israel, it focuses on applications like hip fracture prediction and tumor risk analysis to aid clinical decisions and prevent unnecessary surgeries.
PerSimiO's top competitors include Edge Surgical, Trice Medical and Echolight Medical.
PerSimiO offers Simfini, Simfini-SENIOR, and Simfini-TUMOR.
PerSimiO has 1 investor. Key investors include Ministry of Economy and industry.